e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Epidemiological and clinical aspects of tuberculosis control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment outcome and one year follow-up status of patients treated under DOTS category II
N. Jain, K. K. Sharma, P. Gupta, N. Joshi (Jaipur, India)
Source:
Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Session:
Epidemiological and clinical aspects of tuberculosis control
Session type:
E-Communication Session
Number:
3045
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Jain, K. K. Sharma, P. Gupta, N. Joshi (Jaipur, India). Treatment outcome and one year follow-up status of patients treated under DOTS category II. Eur Respir J 2008; 32: Suppl. 52, 3045
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
To study outcome of directly observered treatment shortcourse (DOTS) category I and category II relapses when put on re-treatment regimen (Cat-II DOTS)
Source: Annual Congress 2011 - Tuberculosis epidemiology and public health
Year: 2011
Ambrisentan therapy for PAH patients with WHO class II symptoms: one year follow-up.
Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension
Year: 2008
Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004
Outcome in DOTS category II patients by strengthening the regimen with daily levofloxacin
Source: Annual Congress 2009 - Tuberculosis control
Year: 2009
Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up
Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases
Year: 2017
Outcome of patients discharged from rapid access lung clinic (RALC) with non cancer diagnosis: Five year follow up
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Treatment outcome and follow-up of new tuberculosis cases discharged from the hospital in 2001
Source: Eur Respir J 2005; 26: Suppl. 49, 647s
Year: 2005
Clinical outcome of adult onset asthma in a 15 year follow-up
Source: Virtual Congress 2020 – Risk factors for chronic lung diseases
Year: 2020
TB status in a dynamic cohort of patients with Inflammatory Bowel Disease receiving immunosuppression treatment, with up to 8 years of follow-up.
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I
Year: 2019
Demographics, clinical course and outcome of children with status asthmaticus treated in a pediatric critical care unit: 8 year review
Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma
Year: 2011
Clinical management improves the treatment outcome of MDR-TB patients
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017
Characteristics of lethal outcomes during the first year of observation in patients with tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 424s
Year: 2005
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Treatment strategies for patients with complex chronic comorbidities
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Asthma control and quality of life in asthmatic patients treated for 6 months with FDC Budesonide/Formoterol - BOREAS study: a subgroup analysis in patients with comorbidities
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Participation in scheduled asthma follow-up contacts and adherence to treatment during 12-year follow-up
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021
Nutrition status and mortality rate during 5-years follow-up in patients with COPD.
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019
Clinical outcome in patients treated with omalizumab during pre-approval period in France
Source: Eur Respir J 2007; 30: Suppl. 51, 621s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept